US Patent 10583172 HPYY(1-36) having a beta-homoarginine substitution at position 35
Patent 10583172 was granted and assigned to Novo Nordisk on March, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 13, 2014
Date of Patent
March 10, 2020
Patent Applicant
Patent Application Number
15036509
Patent Inventor Names
Soeren Oestergaard
0
Birgitte Schjellerup Wulff
0
Jens Kaalby Thomsen
0
Kilian Waldemar Conde Frieboes
0
Birgit Wieczorek
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10583172 HPYY(1-36) having a beta-homoarginine substitution at position 35
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.